Skip to main content

Table 6 Performance of real-time RT-PCR assays targeting the H1av, H1hu, H3, N1 and N2 genes in porcine clinical samples containing European swIAVs

From: Molecular subtyping of European swine influenza viruses and scaling to high-throughput analysis

Clinical samplesa (Panel 3)

M gene RT-qPCR (Cq-value)

Real-time RT-PCRs for molecular subtypingc (Cq-value)

swIAV lineage known from conventional RT-PCRs and commercial H1N1pdm RT-qPCRs

Identification

HA subtyping

NA subtyping

HA

NAb

H1av

H1hu

H3

N1

N2

H1av

N1av

120137–4

20.6

19.19

no Cq

no Cq

19.85

no Cq

120183–5

18.1

19.33

no Cq

no Cq

19.25

no Cq

130004–5

17.59

19.08

no Cq

no Cq

17.75

no Cq

130020–4

26.43

31.38

no Cq

no Cq

26.83

no Cq

130028–3

26.43

22.13

no Cq

no Cq

26.98

no Cq

130065–5

17

23.08

no Cq

no Cq

20.73

no Cq

130144–4

22.26

22.20

no Cq

no Cq

22.46

no Cq

130153–6

22.46

32.33

no Cq

no Cq

22.49

no Cq

130157–6

27.46

24.22

no Cq

no Cq

24.25

no Cq

140014–4

17.56

nt

nt

nt

17.45

no Cq

140016–5

19.09

nt

nt

nt

19.73

no Cq

H1av

N2

120057–3

17.89

17.25

no Cq

no Cq

no Cq

19.72

120345–2

17.51

21.51

no Cq

no Cq

no Cq

20.35

130133–3

21.18

21.67

no Cq

no Cq

no Cq

23.54

110214–1

28.92

27.82

no Cq

no Cq

nt

nt

H1hu

N2

100231-1c

18.57

no Cq

24.79

no Cq

no Cq

21.86

120037–4

23.88

no Cq

27.79

no Cq

no Cq

27.04

120285–6

23.37

no Cq

25.58

no Cq

no Cq

24.45

120424–5

21.32

no Cq

25.43

no Cq

no Cq

24.96

130039–2

22.5

no Cq

22.66

no Cq

no Cq

22.08

130111–5

21

no Cq

22.79

no Cq

no Cq

22.06

130111–6

19.6

nt

nt

nt

no Cq

22.04

130129–4

18.29

no Cq

26.63

no Cq

no Cq

22.58

130193–6

21.95

no Cq

25.36

no Cq

no Cq

24.11

130129–5

17.86

no Cq

27.63

nt

no Cq

22.63

130140–5

13.74

no Cq

20.21

nt

no Cq

16.36

130285–4

29.54

nt

nt

nt

no Cq

27.57

130420–4

22.31

no Cq

23.90

nt

no Cq

24.12

130429–6

22.42

no Cq

24.26

nt

no Cq

21.40

130431–4

15.82

no Cq

18.31

nt

no Cq

17.41

H1hu

N1av

110619–8

17.28

no Cq

21.86

no Cq

18.74

no Cq

120067–3

27.47

no Cq

33.08

no Cq

27.47

no Cq

H1av/H1hu

N2

130103–2

21.46

28.36

23.42

no Cq

22.72

24.56

H1pdm

N1pdm

110578–1

22.16

no Cq

no Cq

no Cq

24.09

no Cq

120158–7

16.97

no Cq

no Cq

no Cq

19.37

no Cq

120333–1

20.08

no Cq

no Cq

no Cq

21.70

no Cq

130116–1

25.21

no Cq

no Cq

no Cq

28.01

no Cq

H3

N2

120031–1

21.83

no Cq

no Cq

22.68

no Cq

24.46

H1av

N?

130044–2

32.18

no Cq

no Cq

nt

30.37

no Cq

130113–2

33.24

no Cq

no Cq

nt

no Cq

no Cq

130120–3

33.91

41.43

no Cq

nt

31.64

no Cq

130135–6

30.77

28.13

no Cq

nt

27.85

no Cq

130175–2

34.36

no Cq

no Cq

nt

no Cq

no Cq

130185–6

27.41

no Cq

no Cq

nt

24.76

no Cq

130188–3

30.5

27.73

no Cq

nt

28.30

no Cq

130236–1

32.88

no Cq

no Cq

nt

no Cq

no Cq

130259–2

33.26

32.05

no Cq

nt

31.22

no Cq

130282–4

27.53

37.19

no Cq

nt

27.45

no Cq

130392–3

31.53

34.52

no Cq

nt

32.07

no Cq

130300–4

31.22

no Cq

no Cq

nt

no Cq

no Cq

130319–5

34.2

no Cq

no Cq

nt

no Cq

no Cq

130336–4

33.7

no Cq

no Cq

nt

no Cq

no Cq

130387–5

23.93

28.20

no Cq

nt

25.70

no Cq

130391–4

34.75

no Cq

no Cq

nt

no Cq

no Cq

130419–6

27.43

no Cq

no Cq

nt

28.53

no Cq

130439–5

29.97

no Cq

no Cq

nt

no Cq

no Cq

H?

N2

130023–4

25.43

no Cq

27.58

nt

no Cq

26.27

130034–3

23.05

no Cq

26.51

nt

no Cq

25.68

130277–3

22

nt

nt

nt

no Cq

24.52

nt

nt

130133–5

23.02

22.90

31.53

nt

no Cq

24.76

  1. aAll samples were nasal swab supernatants except the marked one that was a lung sample. bN1av means that the conventional N1 RT-PCR was positive but the N1pdm commercial RT-qPCR was negative. Call RT-qPCRs were run as monoplex procedures except N1 and N2 that were run in a duplex. Cq: quantification cycle; nt = not tested. Bold data correspond to additional results obtained with the novel RT-qPCRs as compared to conventional RT-PCRs